newsfilter
← Latest News
Business Wire·

Vertex Appoints Daniel Brennan to its Board of Directors

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today announced that Daniel Brennan has been appointed to its Board of Directors as an independent director. Mr. Brennan has more than 35 years of experience in finance